The microRNA -23b/-27b cluster suppresses the metastatic phenotype of castration-resistant prostate cancer cells.
about
MicroRNAs: regulators of cancer metastasis and epithelial-mesenchymal transition (EMT)Uncovering the roles of miRNAs and their relationship with androgen receptor in prostate cancermiR-23b-3p regulates the chemoresistance of gastric cancer cells by targeting ATG12 and HMGB2MicroRNAs in the control of metastatic bone disease.MicroRNA-23b regulates cyclin-dependent kinase-activating kinase complex through cyclin H repression to modulate endothelial transcription and growth under flowThe microRNA-23b/27b/24 cluster promotes breast cancer lung metastasis by targeting metastasis-suppressive gene prosaposin.The microRNA-23b/27b/24-1 cluster is a disease progression marker and tumor suppressor in prostate cancer.MicroRNAs as predictive biomarkers and therapeutic targets in prostate cancer.Dual regulation of receptor tyrosine kinase genes EGFR and c-Met by the tumor-suppressive microRNA-23b/27b cluster in bladder cancer.Therapeutic manipulation of angiogenesis with miR-27bThe reciprocal regulation loop of Notch2 pathway and miR-23b in controlling gastric carcinogenesis.CCL18-mediated down-regulation of miR98 and miR27b promotes breast cancer metastasis.miR-23b as a potential tumor suppressor and its regulation by DNA methylation in cervical cancerMicroRNA-214 Mediates Isoproterenol-induced Proliferation and Collagen Synthesis in Cardiac Fibroblasts.Role of BioResponse 3,3'-Diindolylmethane in the Treatment of Human Prostate Cancer: Clinical Experience.MicroRNA-27b up-regulated by human papillomavirus 16 E7 promotes proliferation and suppresses apoptosis by targeting polo-like kinase2 in cervical cancer.Suppression of hepatic stellate cell activation through downregulation of gremlin1 expression by the miR-23b/27b clusterMicroRNAs and drug resistance in prostate cancers.The role of microRNA in castration-resistant prostate cancer.Breast- and salivary gland-derived adenoid cystic carcinomas: potential post-transcriptional divergencies. A pilot study based on miRNA expression profiling of four cases and review of the potential relevance of the findings.The miRNA23b-regulated signaling network as a key to cancer development--implications for translational research and therapeutics.Functional significance of aberrantly expressed microRNAs in prostate cancer.The Potential of MicroRNAs as Prostate Cancer Biomarkers.Missing link between microRNA and prostate cancer.miR clusters target cellular functional complexes by defining their degree of regulatory freedom.The microRNA-23b/-27b cluster suppresses prostate cancer metastasis via Huntingtin-interacting protein 1-related.Understanding the CREB1-miRNA feedback loop in human malignancies.MicroRNA-27b suppresses growth and invasion of NSCLC cells by targeting Sp1.MicroRNA-23b is an independent prognostic marker and suppresses ovarian cancer progression by targeting runt-related transcription factor-2.MicroRNA-212 inhibits proliferation of gastric cancer by directly repressing retinoblastoma binding protein 2.Different levels of serum microRNAs in prostate cancer and benign prostatic hyperplasia: evaluation of potential diagnostic and prognostic role.Downregulation of mir-23b in plasma is associated with poor prognosis in patients with colorectal cancer.MicroRNA-27b inhibits Spry2 expression and promotes cell invasion in glioma U251 cells.The expression of cysteine-rich secretory protein 2 (CRISP2) and its specific regulator miR-27b in the spermatozoa of patients with asthenozoospermia.microRNA-23b regulates the expression of inflammatory factors in vascular endothelial cells during sepsis.HOTAIR contributes to cell proliferation and metastasis of cervical cancer via targeting miR-23b/MAPK1 axis.PDLIM2 expression is driven by vitamin D and is involved in the pro-adhesion, and anti-migration and -invasion activity of vitamin D.Profiling and bioinformatics analyses of differential circular RNA expression in prostate cancer cellsLong noncoding RNA TOB1-AS1, an epigenetically silenced gene, functioned as a novel tumor suppressor by sponging miR-27b in cervical cancer
P2860
Q26853284-AE92C98E-CF67-4A63-9189-2C95B022592AQ27014171-B566BA22-7B79-4200-B817-15B770BBCB7FQ28606716-EADCBEF0-62EF-48BE-870C-5B1D2148A918Q33821326-5267A955-EF9E-4C4A-9CF8-F2EE9C9117B6Q33993203-9A29F467-219D-456B-A344-934F24FABCA7Q34070330-F652EF39-865A-425D-AA6E-034DA0ABE22BQ34365861-08A6C9CD-0A0B-45BF-A7C8-2F108CF95960Q34448246-B693F5FF-9989-4974-A743-8C3171B09207Q34775805-BEC928AA-7C13-4188-8A3E-E31F592219BAQ35835060-D8A6475B-8948-4185-8E9E-B93E76D2F440Q36228497-3FD145B2-6875-44FE-89C8-867EA72A2886Q36299728-9C383837-57DF-4F90-8029-7EE6DE3E3675Q36330357-6D04EACB-9235-40F1-AE93-DF7E4E8188CCQ36392780-67968247-6E7B-4409-8000-313FCA603341Q36844904-5B540A48-96A6-4A67-95C4-23FD29AF3DD7Q37190143-A4586FBB-1EC1-4C9C-97A5-E28E107A42A6Q37699213-62BCEFC2-C638-4500-9521-D12516C37997Q38205266-5C5A9483-0C3F-4BFF-A100-163C454B1077Q38220789-3647F3DC-34DA-4427-BA5E-53B1EECCD985Q38252816-328B2E8F-C11F-4A53-B049-EFFE31F5C78FQ38258638-8880DCF9-446E-4D72-95AB-B00C6E9D5F57Q38323461-37E4537B-6448-4E83-A7A2-E3471AA4A355Q38710305-2AC4DC81-9BE3-4680-AD8E-AD7DD0315960Q38715316-10C0C09A-41DF-4A45-B99C-C850FAB6F215Q38771877-F00C02DB-2F75-4428-827B-7161BE5A809DQ38792226-2FB472CE-8D60-4081-B3B8-0222C6C7556CQ38802458-56771C36-BFC0-4241-B90D-ADF5A59AC3D5Q38976579-94AE79D0-38C1-4E0E-9A06-BDA3EECC6C3EQ39016879-EE4C4F8C-A72B-40D0-AB44-D6AC4BAE61C5Q39136095-F9D24C72-440C-4D78-A2ED-0ADFBCAF4BE2Q39346497-3BEFC81A-3805-4E22-88BF-54312C3151EBQ41398822-89465880-6709-4334-905E-C1A5127FE108Q41461370-042DF5BE-54AE-420C-A59E-9B041E4275E6Q41693007-5E03DD62-5581-4FAA-BE77-B965F7A6A210Q41866557-D7C6A7B5-E284-4B98-B198-EF2E12579EA2Q50043354-A60E90CA-C179-4092-B69F-41A2DC0457EEQ51069588-A55AEED9-09D7-4287-AA67-51E87600D7A3Q58786195-C931DE3C-6614-47DF-9F9E-478564778CC3Q58804571-C747C8FA-4E4E-4A5D-8ACB-D6F68C7A2BE2
P2860
The microRNA -23b/-27b cluster suppresses the metastatic phenotype of castration-resistant prostate cancer cells.
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
The microRNA -23b/-27b cluster ...... sistant prostate cancer cells.
@ast
The microRNA -23b/-27b cluster ...... sistant prostate cancer cells.
@en
The microRNA -23b/-27b cluster ...... sistant prostate cancer cells.
@nl
type
label
The microRNA -23b/-27b cluster ...... sistant prostate cancer cells.
@ast
The microRNA -23b/-27b cluster ...... sistant prostate cancer cells.
@en
The microRNA -23b/-27b cluster ...... sistant prostate cancer cells.
@nl
prefLabel
The microRNA -23b/-27b cluster ...... sistant prostate cancer cells.
@ast
The microRNA -23b/-27b cluster ...... sistant prostate cancer cells.
@en
The microRNA -23b/-27b cluster ...... sistant prostate cancer cells.
@nl
P2093
P2860
P1433
P1476
The microRNA -23b/-27b cluster ...... sistant prostate cancer cells.
@en
P2093
Derek M Dykxhoorn
Kerry L Burnstein
Reema A Ishteiwy
Toby M Ward
P2860
P304
P356
10.1371/JOURNAL.PONE.0052106
P407
P577
2012-12-26T00:00:00Z